Eleanor Ramos

This profile gathers the share dealings of Eleanor Ramos across 2 companies, led by Global Blood Therapeutics, Inc. and Provention Bio, Inc. We count 6 filings; the first trade dates from 17 August 2015 and the latest from 27 April 2023.

Every open-market trade on record is a purchase: 4 purchases worth €30k, and no sale. The amount is not disclosed for 3 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.

1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 27 April 2023, reports a transaction in Provention Bio, Inc. The most recent open-market purchase was published on 6 December 2021, 1,777 days ago. Filings reach the SEC (Form 4) feed a median of 16 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.